GAIN THERAPEUTICS INC
GANXNASDAQ🏆 #4274 by market capEarnings Nov 18US Equity
$1.20▲ $0.03 (+2.14%)
🌅 Pre-market$1.19▼ 0.40%Regular close · extended-hours price shownTrack GANX
Get earnings, price moves & breaking news on Telegram
24h▲ 2.1%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$51M
Small Cap
📈Revenue Growth (YoY)
0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
—
Insufficient data
GAIN THERAPEUTICS INC
GANXAnalyst Ratings
Price
$1.20
Total
8
Raised
0
Lowered
1
Avg PT
$5.00
H / L
$5 / $5
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-10-05 | — | — |
BTIG | Reiterated | Buy | 2026-08-11 | $5.00 | +318.40% |
Maxim Group | Reiterated | Buy | 2025-10-07 | $7.00 | +485.80% |
Roth Capital | Reiterated | Buy | 2025-08-13 | $10.00 | +736.80% |
Chardan Capital | Reiterated | Buy | 2025-03-28 | $4.00 | +234.70% |
Roth MKM | Reiterated | Buy | 2024-12-24 | — | — |
Oppenheimer | Reiterated | Outperform | 2024-04-23 | — | — |
B. Riley Securities | Downgraded | Buy → Neutral | 2022-08-19 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-10-05
—
—
BTIG
Reiterated · Buy · 2026-08-11
$5.00
+318.40%
Maxim Group
Reiterated · Buy · 2025-10-07
$7.00
+485.80%
Roth Capital
Reiterated · Buy · 2025-08-13
$10.00
+736.80%
Chardan Capital
Reiterated · Buy · 2025-03-28
$4.00
+234.70%
Roth MKM
Reiterated · Buy · 2024-12-24
—
—
Oppenheimer
Reiterated · Outperform · 2024-04-23
—
—
B. Riley Securities
Downgraded · Buy → Neutral · 2022-08-19
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space